{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:37:37Z","timestamp":1788309457775,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier","isbn-type":[{"value":"9780128144190","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.mie.2017.06.039","type":"book-chapter","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T17:55:37Z","timestamp":1512755737000},"page":"217-235","source":"Crossref","is-referenced-by-count":20,"title":["Activity-Based Probes for Glycosidases: Profiling and Other Applications"],"prefix":"10.1016","author":[{"given":"Chi-Lin","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"van Meel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassiani","family":"Kytidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter Willem","family":"Kallemeijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman Stephen","family":"Overkleeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Elena","family":"Artola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Maria","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.mie.2017.06.039_bb0010","article-title":"Roscoe O. Brady: Physician whose pioneering discoveries in lipid biochemistry revolutionized treatment and understanding of lysosomal diseases","author":"Aerts","year":"2017","journal-title":"Blood Cells Molecules and Disease"},{"key":"10.1016\/bs.mie.2017.06.039_bb0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1432-1033.1985.tb09058.x","article-title":"The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen","volume":"150","author":"Aerts","year":"1985","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/bs.mie.2017.06.039_bb0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: Proteins, lipids, and inhibodies","volume":"34","author":"Aerts","year":"2011","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/bs.mie.2017.06.039_bb0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuron.2017.01.018","article-title":"The complicated relationship between Gaucher disease and Parkinsonism: Insights from a rare disease","volume":"93","author":"Aflaki","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/bs.mie.2017.06.039_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0003-9861(92)90685-P","article-title":"Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice","volume":"297","author":"Atsumi","year":"1992","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.mie.2017.06.039_bb0035","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","article-title":"Lysosomal disorders: From storage to cellular damage","volume":"1793","author":"Ballabio","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.mie.2017.06.039_bb0040","doi-asserted-by":"crossref","unstructured":"Barton, N.W., Furbish, F.S., Murray, G.J., Garfield, M., & Brady R.O. (1990). Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proceedings of the National Academy of Sciences of the United States of America, 87, 1913\u20131916. PMID: 2308952; PMC 53594.","DOI":"10.1073\/pnas.87.5.1913"},{"issue":"7","key":"10.1016\/bs.mie.2017.06.039_bb0045","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1021\/acschembio.7b00276","article-title":"Stabilization of glucocerebrosidase by active-site occupancy","volume":"12","author":"Ben Bdira","year":"2017","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/bs.mie.2017.06.039_bb0050","series-title":"Gaucher disease. The metabolic and molecular bases of inherited disease","first-page":"3635","author":"Beutler","year":"2001"},{"key":"10.1016\/bs.mie.2017.06.039_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcmd.2010.10.007","article-title":"A monozygotic twin pair with highly discordant Gaucher phenotypes","volume":"46","author":"Biegstraaten","year":"2011","journal-title":"Blood Cells, Molecules, and Disease"},{"key":"10.1016\/bs.mie.2017.06.039_bb0060","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/bs.mie.2017.06.039_bb0065","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1074\/mcp.O114.041616","article-title":"Broad-range glycosidase activity profiling","volume":"13","author":"Chandrasekar","year":"2014","journal-title":"Molecular and Cellular Proteomics"},{"key":"10.1016\/bs.mie.2017.06.039_bb0070","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/S0140-6736(14)61841-9","article-title":"Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: A phase 3, randomised, open-label, non-inferiority trial","volume":"385","author":"Cox","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/bs.mie.2017.06.039_bb0075","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/bs.mie.2017.06.039_bb0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.75.101304.124125","article-title":"Activity-based protein profiling: From enzyme chemistry to proteomic chemistry","volume":"77","author":"Cravatt","year":"2008","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/bs.mie.2017.06.039_bb0085","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/mt.2015.16","article-title":"Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice","volume":"23","author":"Dahl","year":"2015","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.mie.2017.06.039_bb0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/bst0310523","article-title":"Mapping the conformational itinerary of \u03b2-glycosidases by X-ray crystallography","volume":"31","author":"Davies","year":"2003","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/bs.mie.2017.06.039_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/15227950500405296","article-title":"Perinatal lethal Gaucher disease: A distinct phenotype along the neuronopathic continuum","volume":"24","author":"Eblan","year":"2005","journal-title":"Fetal and Pediatric Pathology"},{"key":"10.1016\/bs.mie.2017.06.039_bb0100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.mie.2017.06.039_bb0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1194\/jlr.M043802","article-title":"Action myoclonus-renal failure syndrome: Diagnostic applications of activity-based probes and lipid analysis","volume":"55","author":"Gaspar","year":"2014","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.mie.2017.06.039_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138107","article-title":"Visualization of active glucocerebrosidase in rodent brain with high spatial resolution following in situ labeling with fluorescent activity based probes","volume":"10","author":"Herrera Moro Chao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.mie.2017.06.039_bb0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Human Mutation"},{"key":"10.1016\/bs.mie.2017.06.039_bb0120","doi-asserted-by":"crossref","first-page":"10861","DOI":"10.1002\/chem.201501313","article-title":"Comparing cyclophellitol N-alkyl and N-acyl cyclophellitol aziridines as activity-based glycosidase probes","volume":"21","author":"Jiang","year":"2015","journal-title":"Chemistry"},{"key":"10.1016\/bs.mie.2017.06.039_bb0125","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/C4SC03739A","article-title":"In vitro and in vivo comparative and competitive activity-based protein profiling of GH29 \u03b1-L-fucosidases","volume":"6","author":"Jiang","year":"2015","journal-title":"Chemical Science"},{"key":"10.1016\/bs.mie.2017.06.039_bb0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/acscentsci.6b00057","article-title":"Detection of active mammalian GH31 \u03b1-glucosidases in health and disease using in-class, broad-spectrum activity-based probes","volume":"2","author":"Jiang","year":"2016","journal-title":"ACS Central Science"},{"key":"10.1016\/bs.mie.2017.06.039_bb0135","doi-asserted-by":"crossref","first-page":"12529","DOI":"10.1002\/anie.201207771","article-title":"Novel activity-based probes for broad-spectrum profiling of retaining \u03b2-exoglucosidases in situ and in vivo","volume":"51","author":"Kallemeijn","year":"2012","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/bs.mie.2017.06.039_bb0140","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/cbic.201600312","article-title":"Endo-\u03b2-glucosidase tag allows dual detection of fusion proteins by fluorescent mechanism-based probes and activity measurement","volume":"17","author":"Kallemeijn","year":"2016","journal-title":"ChemBioChem"},{"key":"10.1016\/bs.mie.2017.06.039_bb0145","doi-asserted-by":"crossref","first-page":"35351","DOI":"10.1074\/jbc.M114.593376","article-title":"A sensitive gel-based method combining distinct cyclophellitol-based probes for the identification of acid\/base residues in human retaining \u03b2-glucosidases","volume":"289","author":"Kallemeijn","year":"2014","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2017.06.039_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-800128-8.00004-2","article-title":"Mechanism-based inhibitors of glycosidases: Design and applications","volume":"71","author":"Kallemeijn","year":"2014","journal-title":"Advances in Carbohydrate Chemistry Biochemistry"},{"key":"10.1016\/bs.mie.2017.06.039_bb0155","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1469-185X.1953.tb01386.x","article-title":"Stereochemistry and mechanism of enzymatic reactions","volume":"28","author":"Koshland","year":"1953","journal-title":"Biological Reviews of the Cambridge Philosophical Society"},{"key":"10.1016\/bs.mie.2017.06.039_bb0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/hch036","article-title":"Twin pairs showing discordance of phenotype in adult Gaucher's disease","volume":"97","author":"Lachmann","year":"2004","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1016\/bs.mie.2017.06.039_bb0165","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1039\/C4OB01611D","article-title":"Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors","volume":"12","author":"Li","year":"2014","journal-title":"Organic and Biomolecular Chemistry"},{"key":"10.1016\/bs.mie.2017.06.039_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135889","article-title":"Reducing GBA2 activity ameliorates neuropathology in Niemann-Pick type C mice","volume":"10","author":"Marques","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/bs.mie.2017.06.039_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cbic.201600561","article-title":"A specific activity-based probe to monitor family GH59 galactosylceramidase, the enzyme deficient in Krabbe disease","volume":"18","author":"Marques","year":"2017","journal-title":"ChemBioChem"},{"key":"10.1016\/bs.mie.2017.06.039_bb0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.mie.2017.06.039_bb0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev-biochem-060713-035708","article-title":"Enzyme inhibitor discovery by activity-based protein profiling","volume":"83","author":"Niphakis","year":"2014","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/bs.mie.2017.06.039_bb0190","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrc2901","article-title":"Activity-based protein profiling for biochemical pathway discovery in cancer","volume":"10","author":"Nomura","year":"2010","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/bs.mie.2017.06.039_bb0195","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1039\/C6CC01564F","article-title":"Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: Lessons from Gaucher, GM1-gangliosidosis and Fabry diseases","volume":"52","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Chemical Communications"},{"key":"10.1016\/bs.mie.2017.06.039_bb0200","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1038\/nprot.2007.365","article-title":"Cryosectioning and immunolabeling","volume":"2","author":"Slot","year":"2007","journal-title":"Nature Protocols"},{"key":"10.1016\/bs.mie.2017.06.039_bb0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1432-1033.1990.tb19173.x","article-title":"Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase","volume":"191","author":"Van Weely","year":"1990","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/bs.mie.2017.06.039_bb0210","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1367-5931(02)00380-0","article-title":"Glycosidase mechanisms","volume":"6","author":"Vasella","year":"2002","journal-title":"Current Opinion in Chemical Biology"},{"key":"10.1016\/bs.mie.2017.06.039_bb0215","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1002\/anie.200902620","article-title":"Glycosphingolipids\u2014Nature, function, and pharmacological modulation","volume":"48","author":"Wennekes","year":"2009","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/bs.mie.2017.06.039_bb0220","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1021\/ja507040n","article-title":"Potent and selective activity-based probes for GH27 human retaining \u03b1-galactosidases","volume":"136","author":"Willems","year":"2014","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/bs.mie.2017.06.039_bb0225","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nchembio.466","article-title":"Ultrasensitive in situ visualization of active glucocerebrosidase molecules","volume":"6","author":"Witte","year":"2010","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/bs.mie.2017.06.039_bb0230","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1039\/c1ob05531c","article-title":"Irreversible inhibitors and activity-based probes as research tools in chemical glycobiology","volume":"9","author":"Witte","year":"2011","journal-title":"Organic and Biomolecular Chemistry"},{"key":"10.1016\/bs.mie.2017.06.039_bb0235","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1039\/b408880h","article-title":"Nature's many mechanisms for the degradation of oligosaccharides","volume":"2","author":"Yip","year":"2004","journal-title":"Organic and Biomolecular Chemistry"}],"container-title":["Methods in Enzymology","Chemical Glycobiology Part B. Monitoring Glycans and their Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687917302227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687917302227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T16:14:44Z","timestamp":1530288884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0076687917302227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128144190"],"references-count":46,"URL":"https:\/\/doi.org\/10.1016\/bs.mie.2017.06.039","relation":{},"ISSN":["0076-6879"],"issn-type":[{"value":"0076-6879","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}